Bayer Aktiengesellschaft (LON:0P6S)

Revenue

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Crop Science Revenue	21.61B	22.26B	Log In	Log In	Log In	Upgrade
Pharmaceuticals Revenue	18.01B	18.13B	Log In	Log In	Log In	Upgrade
Consumer Health Revenue	5.91B	5.87B	Log In	Log In	Log In	Upgrade
All Other Segment Revenue	-	327.00M	Log In	Log In	Log In	Upgrade
Enabling Functions and Consolidation Revenue	-	19.00M	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Europe/Middle East/Africa Revenue	13.60B	13.98B	Log In	Log In	Log In	Upgrade
North America Revenue	16.67B	16.48B	Log In	Log In	Log In	Upgrade
Asia/Pacific Revenue	7.89B	8.07B	Log In	Log In	Log In	Upgrade
Latin America Revenue	7.71B	8.08B	Log In	Log In	Log In	Upgrade

Adjusted EBITDA

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	2011 - 2020
Crop Science Adjusted EBITDA	4.34B	4.33B	Log In	Log In	Log In	Upgrade
Pharmaceuticals Adjusted EBITDA	4.59B	4.72B	Log In	Log In	Log In	Upgrade
Consumer Health Adjusted EBITDA	1.40B	1.37B	Log In	Log In	Log In	Upgrade
All Other Segment Adjusted EBITDA	-	62.00M	Log In	Log In	Log In	Upgrade
Enabling Functions and Consolidation Adjusted EBITDA	-	-352.00M	Log In	Log In	Log In	Upgrade

Updated Sep 30, 2025. Data Source: Fiscal.ai.